The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.
MING FONG will participate in the prestigious MD&M West trade show, bringing its cutting-edge expertise to the forefront. The company aims to showcase its one-stop service capabilities, which ...
A CergenX-led consortium, including UCC/ INFANT, was awarded €6.7 million in funding from The Disruptive Technologies Innovation Fund (DTIF), to develop CergenX Wave, an automated AI assessment to ...